Pine Labs IPO Fund Utilization: CARE Ratings Confirms Adherence, Notes Minor Correction

Pine Labs has utilized ₹797.28 crore of its ₹2,080.00 crore IPO proceeds as of March 31, 2026. CARE Ratings confirmed fund deployment largely aligns with prospectus objectives, noting a corrected Q3FY26 expense discrepancy.

Report Details IPO Fund Use

Pine Labs' IPO monitoring agency, CARE Ratings, has submitted its report for the quarter ending March 31, 2026. The report confirms that IPO proceeds utilization is largely in line with the company's prospectus objectives. By the end of Q4 FY26, a total of ₹797.28 crore out of the ₹2,080.00 crore IPO issue size had been deployed. This deployment covers ₹59.99 crore for subsidiaries, ₹106.17 crore for IT assets and cloud infrastructure, and ₹7.40 crore for general corporate purposes. The report also noted and has since corrected a minor discrepancy in Q3 FY26 issue expense reporting, amounting to ₹12.96 crore.

Investor Assurance and Governance

This filing offers investors assurance that capital is being managed and deployed according to the original plans. It signals adherence to strong corporate governance and financial transparency after the IPO. The ongoing deployment supports Pine Labs' strategic initiatives, aimed at driving future growth and market expansion.

About Pine Labs

Pine Labs is a leading Indian fintech company offering a wide range of payment solutions. Its services include point-of-sale (POS) terminals, digital payments, and buy-now-pay-later (BNPL) options for merchants and consumers. The company raised ₹2,080.00 crore through its IPO, detailing plans in its prospectus to use these funds for expansion, technology investment, and general corporate purposes.

Impact on Investor Confidence

Investors gain confidence that IPO capital is being channelled into strategic growth areas as promised. Correcting a minor reporting error demonstrates a commitment to financial accuracy and transparency. The remaining ₹1,282.72 crore in unutilized proceeds offers flexibility for future strategic moves. Confirmation of adherence to the prospectus can positively influence market perception of the company's management.

Potential Risks

While corrected, the identified Q3 FY26 expense reporting discrepancy hints at potential oversights in financial documentation processes. The primary risk remains the effective long-term deployment of the significant unutilized IPO proceeds.

Peer Comparison

Paytm (One 97 Communications): As a prominent listed Indian fintech, Paytm also focuses on scaling payment infrastructure and expanding merchant services. Its investor reports detail fund deployment for technology, marketing, and business expansion.

Note: Many direct competitors, such as PhonePe and Razorpay, are privately held.

Key Figures

• Total IPO Proceeds Utilized: ₹797.28 crore (as of Q4 FY26, consolidated).
• Total Unutilized IPO Proceeds: ₹1,282.72 crore (as of Q4 FY26, consolidated).
• Q3 FY26 Issue Expense Discrepancy (Corrected): ₹12.96 crore (standalone).

Looking Ahead

Subsequent reports from the monitoring agency detailing the utilization of remaining IPO funds. Pine Labs' progress on expansion into new markets and technology development projects. Performance of investments in IT assets and cloud infrastructure. The company's overall financial health and growth trajectory post-IPO. Any new strategic partnerships or funding rounds.